|
|
|
|
Vol. 63, Issue 4, 844-848, April 2003
Graduate School of Pharmaceutical Sciences, University of Tokyo,
Tokyo, Japan (D.-S.W., H.K., Y.K., Y.S.); Division of Experimental
Therapy, the Netherlands Cancer Institute, Amsterdam, the Netherlands
(J.W.J., A.H.S.); and Core Research for Evolutional Science and
Technology, Japan Science and Technology Corporation, Tokyo, Japan
(H.K., Y.K., Y.S.)
Biguanides are a class of drugs widely used as oral antihyperglycemic
agents for the treatment of type 2 diabetes mellitus, but they are
associated with lactic acidosis, a lethal side effect. We reported
previously that biguanides are good substrates of rat organic cation
transporter 1 (Oct1; Slc22a1) and, using Oct1(
/
) mice, that mouse Oct1 is responsible for the hepatic uptake of a
biguanide, metformin. In the present study, we investigated whether the
liver is the key organ for the lactic acidosis. When mice were given
metformin, the blood lactate concentration significantly increased in
the wild-type mice, whereas only a slight increase was observed in
Oct1(
/
) mice. The plasma concentration of metformin exhibited
similar time profiles between the wild-type and Oct1(
/
) mice,
suggesting that the liver is the key organ responsible for the lactic
acidosis. Furthermore, the extent of the increase in blood lactate
caused by three different biguanides (metformin, buformin, and
phenformin) was compared with the abilities to reduce oxygen
consumption in isolated rat hepatocytes. When rats were given each of
these biguanides, the lactate concentration increased significantly.
This effect was dose-dependent, and the EC50 values of
metformin, buformin, and phenformin were 734, 119, and 4.97 µM,
respectively. All of these biguanides reduced the oxygen consumption by
isolated rat hepatocytes in a concentration-dependent manner. When the
concentration required to reduce the oxygen consumption to 75% of the
control value (from 0.40 to 0.29 µmol/min/mg protein) was compared
with the EC50 value obtained in vivo, a clear correlation was observed among the three biguanides, suggesting that oxygen consumption in isolated rat hepatocytes can be used as an index of the
incidence of lactic acidosis.
This article has been cited by other articles:
![]() |
T. Maeda, M. Oyabu, T. Yotsumoto, R. Higashi, K. Nagata, Y. Yamazoe, and I. Tamai Effect of Pregnane X Receptor Ligand on Pharmacokinetics of Substrates of Organic Cation Transporter Oct1 in Rats Drug Metab. Dispos., September 1, 2007; 35(9): 1580 - 1586. [Abstract] [Full Text] [PDF] |
||||
![]() |
H.-J. Kang, I.-S. Song, H. J. Shin, W.-Y. Kim, C.-H. Lee, J.-C. Shim, H.-H. Zhou, S. S. Lee, and J.-G. Shin Identification and Functional Characterization of Genetic Variants of Human Organic Cation Transporters in a Korean Population Drug Metab. Dispos., April 1, 2007; 35(4): 667 - 675. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. Ren, J. He, H. Jiang, L. Zu, S. Pu, X. Guo, and G. Xu Metformin reduces lipolysis in primary rat adipocytes stimulated by tumor necrosis factor-{alpha} or isoproterenol. J. Mol. Endocrinol., August 1, 2006; 37(1): 175 - 183. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. W. Jonker and A. H. Schinkel Pharmacological and Physiological Functions of the Polyspecific Organic Cation Transporters: OCT1, 2, and 3 (SLC22A1-3) J. Pharmacol. Exp. Ther., January 1, 2004; 308(1): 2 - 9. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. W. Jonker, E. Wagenaar, S. van Eijl, and A. H. Schinkel Deficiency in the Organic Cation Transporters 1 and 2 (Oct1/Oct2 [Slc22a1/Slc22a2]) in Mice Abolishes Renal Secretion of Organic Cations Mol. Cell. Biol., November 1, 2003; 23(21): 7902 - 7908. [Abstract] [Full Text] [PDF] |
||||